{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:20Z","timestamp":1767134780545,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007822","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T00:00:00Z","timestamp":1276646400000}}],"reference-count":45,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007822.pub2","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T12:02:28Z","timestamp":1276603348000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer"],"prefix":"10.1002","volume":"2018","author":[{"given":"Khadra","family":"Galaal","sequence":"first","affiliation":[{"name":"Princess Alexandra Wing, Royal Cornwall Hospital; Gynaecological Oncology; Truro UK TR1 3LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Naik","sequence":"additional","affiliation":[{"name":"Northern Gynaecological Oncology Centre; Gynaecological Oncology; Queen Elizabeth Hospital Gateshead Tyne and Wear UK NE9 6SX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E","family":"Bristow","sequence":"additional","affiliation":[{"name":"University of California - Irvine, Medical Center; Division of Gynecologic Oncology; Building 56, Room 260 101 The City Drive Orange CA USA 92868"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Patel","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol NHS Foundation Trust; Gynaecological Oncology; St Michaels Hospital Southwell Street Bristol UK BS2 8EG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather O","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"10.1002\/14651858.CD007822.pub2-BIB0001|cit1","unstructured":"Harter P Kurzeder C du Bios A A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer ClinicalTrials.gov Identifier: NCT01166737 2012"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0002|cit2","first-page":"326","article-title":"The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery","volume":"25","author":"Boente","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007822.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD007822.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"No. 6","key":"10.1002\/14651858.CD007822.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The Results of Direct and Indirect Treatment Comparisons in Meta-Analysis of Randomized Controlled Trials","volume":"Vol. 50","author":"Bucker","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0889-8545(21)00314-4","article-title":"Secondary cytoreductive surgery for ovarian cancer\u00a0","volume":"21","author":"Burke","year":"1994","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0008|cit8","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE) (http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf)"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0009|cit9","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0090-8258(84)90040-4","article-title":"Stage III epithelial ovarian cancer: the role of maximal surgical reduction","volume":"18","author":"Delgado","year":"1984","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary","volume":"14 (Supplement","author":"Sant","year":"2003","journal-title":"Annals of Oncology"},{"issue":"9","key":"10.1002\/14651858.CD007822.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/IGC.0b013e3181a8407e","article-title":"Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer","volume":"19","author":"Ferrero","year":"2009","journal-title":"Internnational Journal of Gynecologic Cancer"},{"issue":"3","key":"10.1002\/14651858.CD007822.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0016|cit16","unstructured":"Ferlay J Bray F Pisani P Parkin DM GLOBOCAN 2002.\u00a0 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0.\u00a0 IARCPress, Lyon 2004"},{"issue":"10","key":"10.1002\/14651858.CD007822.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z","article-title":"Ovarian carcinoma diagnosis","volume":"89","author":"Goff","year":"2000","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0018|cit18","first-page":"abs 1812","article-title":"Randomized phaseII study of carboplatin versus paclitaxel-carboplatin in platinum sensitive recurrent advanced ovarian carcinoma with assessment of quality of life","volume":"22","author":"Gonzalez-Martin","year":"2003","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD007822.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2004.11.057","article-title":"The role of secondary cytoreductive surgery for recurrent ovarian cancer","volume":"97","author":"Gungor","year":"2005","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0020|cit20","first-page":"413","article-title":"Primarycytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD007822.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1702-10","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)DESKTOP OVAR Trial","volume":"13","author":"Harter","year":"2006","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD007822.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/era.09.165","article-title":"Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs","volume":"10","author":"Harter","year":"2010","journal-title":"Expert Reviews in Anticancer Therapy"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with sub optimal residual epithelial ovarian carcinoma","volume":"70","author":"Hoskins","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0026|cit26","article-title":"Cancer Incidence in Five Continents, Volume VIII","volume-title":"IARC Scientific Publication No. 155","author":"Parkin","year":"2002"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0027|cit27","first-page":"71","article-title":"Cancer Statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Johnson NP Selman T Zamora J Khan KS Gynaecologic surgery from uncertainty to science: evidence-based surgery is no passing fad Reproduction Advanced Access 2008","DOI":"10.1093\/humrep\/dem423"},{"issue":"15","key":"10.1002\/14651858.CD007822.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2004.05.195","article-title":"Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design","volume":"22","author":"Markman","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/IGC.0b013e3181c104fa","article-title":"Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds","volume":"S2","author":"Monk","year":"2009","journal-title":"International Journal of Gynecological Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007822.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2004.09.018","article-title":"Critical evaluation of secondary cytoreduction in recurrent ovarian cancer","volume":"95","author":"Munkarah","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0032|cit32","first-page":"895","article-title":"Epithelial ovarian cancer","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Ozols","year":"2005"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17(24)","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer. the ICON4\/AGO-OVAR-2-2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.1988.6.6.983","article-title":"The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in Stage III and IV ovarian carcinoma","volume":"6","author":"Piver","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"686-90","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6404","article-title":"Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"83","author":"Scarabelli","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0038|cit38","first-page":"1","article-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament","volume-title":"Atlas of tumor pathology","volume":"fascicle 23 3rd","author":"Scully","year":"1998"},{"issue":"9","key":"10.1002\/14651858.CD007822.pub2-BIB0039|cit39","first-page":"1529","article-title":"Phase 2 trial of docetaxel, gemcitabine and oxliplatin combination in platinum-pretreated epithelial ovarian cancer","volume":"19","author":"Selinger","year":"2009","journal-title":"International Journal of Gynecological Cancer"},{"issue":"8","key":"10.1002\/14651858.CD007822.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD007822.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/cncr.21310","article-title":"Ovarian cancer: can we make the clinical diagnosis earlier","volume":"104","author":"Smith","year":"2005","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD007822.pub2-BIB0042|cit42","first-page":"1008","article-title":"Secondary Cytoreductive Surgery for RecurrentEpithelial Ovarian Cancer","volume":"99","author":"Tay","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD007822.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.04.006","article-title":"Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"106","author":"Tebes","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007822.pub2-BIB0044|cit44","first-page":"4195","article-title":"Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial","volume":"29","author":"Weber\u00a0B","year":"2009 Oct","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD007822.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21969","article-title":"Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis","volume":"107","author":"Wright","year":"2006","journal-title":"Cancer"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007822.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:02:06Z","timestamp":1674036126000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007822.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007822.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}